目次

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape

2 Market Overview
2.1. Market definition
2.2. Market analysis

3 Market Data
3.1. Market value

4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation

5 Market Outlook
5.1. Market value forecast

6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. What has been the rationale behind recent M&A activity?

8 Company Profiles
8.1. F. Hoffmann-La Roche Ltd
8.2. Novartis AG
8.3. BioNTech SE
8.4. AstraZeneca PLC
8.5. Bayer AG

9 Macroeconomic Indicators
9.1. Country data

10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List of Tables
Table 1: Europe biotechnology industry value: $ billion, 2016-21
Table 2: Europe biotechnology industry category segmentation: % share, by value, 2016-2021
Table 3: Europe biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: Europe biotechnology industry geography segmentation: $ billion, 2021
Table 5: Europe biotechnology industry value forecast: $ billion, 2021-26
Table 6: F. Hoffmann-La Roche Ltd: key facts
Table 7: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 8: F. Hoffmann-La Roche Ltd: Key Employees
Table 9: Novartis AG: key facts
Table 10: Novartis AG: Annual Financial Ratios
Table 11: Novartis AG: Key Employees
Table 12: Novartis AG: Key Employees Continued
Table 13: BioNTech SE: key facts
Table 14: BioNTech SE: Annual Financial Ratios
Table 15: BioNTech SE: Key Employees
Table 16: AstraZeneca PLC: key facts
Table 17: AstraZeneca PLC: Annual Financial Ratios
Table 18: AstraZeneca PLC: Key Employees
Table 19: Bayer AG: key facts
Table 20: Bayer AG: Annual Financial Ratios
Table 21: Bayer AG: Key Employees
Table 22: Bayer AG: Key Employees Continued
Table 23: Europe size of population (million), 2017-21
Table 24: Europe gdp (constant 2005 prices, $ billion), 2017-21
Table 25: Europe gdp (current prices, $ billion), 2017-21
Table 26: Europe inflation, 2017-21
Table 27: Europe consumer price index (absolute), 2017-21
Table 28: Europe exchange rate, 2017-21

List of Figures
Figure 1: Europe biotechnology industry value: $ billion, 2016-21
Figure 2: Europe biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: Europe biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: Europe biotechnology industry value forecast: $ billion, 2021-26
Figure 5: Forces driving competition in the biotechnology industry in Europe, 2021
Figure 6: Drivers of buyer power in the biotechnology industry in Europe, 2021
Figure 7: Drivers of supplier power in the biotechnology industry in Europe, 2021
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Europe, 2021
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Europe, 2021
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Europe, 2021